Dynamics of fractalkine among Kharkiv residents with different body mass
Full Text:PDF (Українська)
World Health Organization. Obesity and overweight. 2016. www.who.int/mediacentre/factsheets/fs311/en/
Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014 Mar;383(9921):970-83. doi: 10.1016/S0140–6736 (13)61836-X.
Cancello R, Henegar C, Viguerie N, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005;54(8):2277-86. PMID: 16046292.
Cancello R, Tordjman J, Poitou C. et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes. 2006;55(6):1554-61. doi: 10.2337/db06-0133.
Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005;46(11):2347-55. doi: 10.1194/jlr.M500294-JLR200.
Kang K, Reilly SM, Karabacak V, et al. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab. 2008;7(6):485-95. doi: 10.1016/j.cmet.2008.04.002.
Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006 Jun;116(6):1494-505. doi: 10.1172/JCI26498.
Garton KJ, Gough PJ, Blobel CP, et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem. 2001;276(41):7993-8001. doi: 10.1074/jbc.M106434200.
Hundhausen C, Misztela D, Berkhout TA, et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood. 2003;102(4):1186-95. doi: 10.1182/blood-2002-12-3775.
Hyakudomi M, Matsubara T, Hyakudomi R, et al. Increased expression of fractalkine is correlated with a better prognosis and an increased number of both CD8+ T cells and natural killer cells in gastric adenocarcinoma. Ann Surg Oncol. 2008;15(6):1775-82. doi: 10.3748%2Fwjg.v20.i15.4428.
Ikejima H, Imanishi T, Tsujioka H, et al. Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris. Circulation J. 2010;74(2):337-45. PMID: 20019415.
Liu H, Jiang D, Zhang S, Ou B. Aspirin inhibits fractalkine expression in atherosclerotic plaques and reduces atherosclerosis in ApoE gene knockout mice. Cardiovascular Drugs and Therapy. 2010 Feb;24(1):17-24. doi: 10.1007/s10557-009-6210-7.
White GE, Tan TC, John AE, et al. Fractalkine has antiapoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signaling. Cardiovascular Res. 2010;85:825-35. doi: 10.1093/cvr/cvp341.
Schäfer A, Schulz C, Fraccarollo D, et al. The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions. Arterioscler Thromb Vasc Biol. 2007;27(1):55-62. doi: 10.1161/01.ATV.0000251535.30191.60.
Garvey WT, Garber AJ, Mechanick JI, Bray GA, et al. The American Association of Clinical Endocrinologists and the American College of Endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocr Pract. 2014 Sep; 20(9):977-89. doi: 10.4158/EP14280.PS.
This work is licensed under a Creative Commons Attribution 4.0 International License.
© "Publishing House "Zaslavsky", 1997-2019